SCI logo
All TrialsFAQAbout

All trials - page: 292

All trials

Displaying of results
Download as CSV
NCTID
Brief title
Sponsor
Design
Criteria
Status
Target enrollment
Study phase & design
Primary intervention type
Primary potential benefit
Outcome measure
Follow up
Start date
First posted
Location
NCT04727866Brain Plus Spinal Stimulation for Cervical SCIBronx VA Medical Center
  • Age 18 - 75 yrs
  • Level C1-C8
    • AIS A, B, C, D
  • ≥ 12 months
  • NOT have an implanted device, e.g. stimulator or pacemaker
Ended24NATechnologyArm/hand function04 January 202127 January 20212
NCT04736849Epidural and Dorsal Root Stimulation in Humans With Spinal Cord InjuryMayo Clinic
  • Age ≥ 22 yrs
  • Level C7-T10
    • AIS A, B, C, D
  • ≥ 1 years
  • NOT have a body mass > 113 kg (250 pounds)
  • NOT have a history of cardiopulmonary disorder
  • NOT have a history of seizures
Ended22NATechnologyGeneral health24 September 202103 February 20211
NCT04807764Transspinal Stimulation Plus Locomotor Training for SCICity University of New York
  • Age 18 - 70 yrs
  • Level C1-T9
    • AIS C, D
  • 6 months - 70 years
  • NOT have an implanted device, e.g. pacemaker
  • NOT have cardiopulmonary disease or cognitive impairment
  • NOT have other neurological disorders (e.g., peripheral neuropathy)
  • NOT have history of seizures
Ended14NATechnologyStanding/walking/mobility01 August 202119 March 20213
NCT04809987Effectiveness of Virtual Gait System Intervention in Motor Function in People with Incomplete Spinal Cord Injury.University of Valencia
  • Age 16 - 99 yrs
  • Level C1-S5
    • AIS C, D
  • ≤ 99 years
  • NOT have other nervous system alterations
  • NOT have a vestibular disease
Active38NARehabilitationStanding/walking/mobility30 January 202122 March 20212
NCT04812431Safety and Exploratory Efficacy of Transplantation Therapy Using PSA-NCAM(+) NPC in AIS-A Level of Sub-acute SCIS.Biomedics Co., Ltd.
  • Age 18 - 65 yrs
  • Level C4-C7
    • AIS A
  • 7 days - 60 days
  • NOT have penetrating injury, e.g. gunshot or knife wound
  • NOT have history of malignant tumor
  • NOT have immunodeficiency
  • NOT have unstable or untreated psychiatric disorder
Recruiting5PHASE1, PHASE2Biological/cell basedGeneral health23 September 202123 March 20214
NCT04821635Effects of FES-Rowing in Neurological Disorders (FES-ROW)UGECAM Rhône-Alpes
  • Age ≥ 18 yrs
  • Level C1-S5
    • AIS A, B
  • ≥ 12 months
  • NOT have shoulder issues that would compromise use of rower
  • NOT have other neurological condition (head trauma, stroke, peripheral myopathy, etc.)
  • NOT have lower limb spasticity
Ended0NATechnologyGeneral health01 April 202429 March 20212

Proudly supported by

Trial table